Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Ergomed celebrates fourth licensing deal for anti-cancer compound

Thursday, October 13, 2016 23:53
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Clinical services specialist Ergomed Plc (LON:ERGO) said its co-development partner AEterna Zentaris Inc (TSE:AEX, NASDAQ:AEZS) has signed an additional licensing deal for cancer drug Zoptrex.

AEterna Zentaris signed an exclusive licence agreement with Specialised Therapeutics Asia for Zoptrex, covering the territories of Australia and New Zealand. It is the fourth licensing agreement for AEterna’s lead anti-cancer compound.

AEterna will receive an up-front payment plus milestone payments and royalties, while Ergomed will receive a portion of all revenues generated from the commercialisation of the product.

Zoptrex is currently in a fully-enrolled Phase 3 clinical trial for patients with cancer of the womb or uterus.  If the results of the trial warrant doing so, AEterna will submit a new drug application for Zoptrex to the United States Food and Drug Administration in 2017.

“This licensing agreement for Australia and New Zealand adds another two territories to the overall coverage now for Zoptrex and demonstrates the value of our co-development business,” said Dr Miroslav Reljanovic. 

“In line with our strategy to expand our co-development business, we also recently announced a new partnership, which, together with this licensing agreement, further validates our hybrid business model,” he added.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.